Cathelicidin as a marker of worsening of the course of lung infection

T. Luchnikova (Blagoveshchensk (Amur Oblast), Russian Federation), O. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation), I. Menshikova (Blagoveshchensk (Amur Oblast), Russian Federation), T. Talchenkova (Blagoveshchensk (Amur Oblast), Russian Federation)

Source: Virtual Congress 2021 – Back to infection basics
Session: Back to infection basics
Session type: E-poster
Number: 2357

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Luchnikova (Blagoveshchensk (Amur Oblast), Russian Federation), O. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation), I. Menshikova (Blagoveshchensk (Amur Oblast), Russian Federation), T. Talchenkova (Blagoveshchensk (Amur Oblast), Russian Federation). Cathelicidin as a marker of worsening of the course of lung infection. 2357

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Age-related pattern of childhood lung infection and its complications
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189
Year: 2002

Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021


Inflammation, infection and early lung damage
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


CT patterns of lung damage and prognosis markers for the course of a new coronavirus infection COVID-19 in persons with comorbidity
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease?
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
Source: Annual Congress 2013 –COPD and infections
Year: 2013


A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019



The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis
Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018
Year: 2019



COVID19 coinfection exacerbates lung inflammation in TB patients.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019



Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at the time of diagnosis
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

The role of infection in the development of chronic lung disease of prematurity
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007


Th1\Th2 lymphocyte response during the course of lung infection in CF children
Source: Eur Respir J 2006; 28: Suppl. 50, 484s
Year: 2006

Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function
Source: ERJ Open Res, 7 (3) 00365-2021; 10.1183/23120541.00365-2021
Year: 2021



Effects of lung development on pulmonary function tests: from early life to chronic respiratory disease
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020


E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016